Biotech Updates

Pairwise Licenses Gene Editing Platform to CIMMYT

June 18, 2025

Pairwise has entered a landmark licensing agreement with the International Maize and Wheat Improvement Center (CIMMYT) to provide access to its Fulcrum™ gene editing platform, including the advanced SHARC™ CRISPR enzyme. This partnership will accelerate the development of improved crop varieties for smallholder farmers across 20 countries.

The Fulcrum™ Platform includes Pairwise-developed gene editing tools for cutting, base editing, and templated editing. It is a toolbox that enables not only turning a characteristic on or off but also tuning it, like a dimmer switch, to tailor the trait and deliver the optimum phenotype.

"Our Fulcrum Platform was built to help scientists solve urgent, real-world challenges in agriculture," said Ian Miller, Chief Operating Officer at Pairwise. "This agreement allows CIMMYT to use our powerful CRISPR tools to deliver real-world improvements for farmers facing food insecurity and climate pressure," he added.

For more details, read the news article on the CIMMYT website.


You might also like: